Transcatheter Tricuspid Valve Replacement: Illustrative Case Reports and Review of State-of-Art

Overview

Journal J Clin Med

Specialty General Medicine

Date 2023 Feb 25

PMID 36835907

Authors

Manuel Barreiro-Perez

Rocio Gonzalez-Ferreiro

Berenice Caneiro-Queija

Marta Tavares-Silva

Luis Puga

Jose A Parada-Barcia

Alvaro Rodriguez-Perez

Jose A Baz-Alonso

Miguel A Pinon-Esteban

Rodrigo Estevez-Loureiro

Andres Iniguez-Romo

Affiliations

Soon will be listed here.

Abstract

Tricuspid regurgitation (TR) is one of the most common heart valve diseases, associated a with poor prognosis since significant TR is associated with an increased mortality risk compared to no TR or mild regurgitation. Surgery is the standard treatment for TR, although it is associated with high morbidity, mortality, and prolonged hospitalization, particularly in tricuspid reoperation after left-sided surgery. Thus, several innovative percutaneous transcatheter approaches for repair and replacement of the tricuspid valve have gathered significant momentum and have undergone extensive clinical development in recent years, with favorable clinical outcomes in terms of mortality and rehospitalization during the first year of follow-up. We present three clinical cases of transcatheter tricuspid valve replacement in an orthotopic position with two different innovative systems along with a review of the state-of-the-art of this emergent topic.

Citing Articles

Transcatheter Management of Tricuspid Regurgitation: A Review of Contemporary Evidence.

Sammour Y, Anwaar M, Cabral-Amador F, Garcia J, Aoun J, Kazmi S Heart Int. 2025; 18(2):24-36.

PMID: 39885934 PMC: 11781372. DOI: 10.17925/HI.2024.18.2.4.

New Therapeutic Advances in the Management of Tricuspid Valve Regurgitation.

Synetos A, Ktenopoulos N, Katsaros O, Vlasopoulou K, Korovesis T, Drakopoulou M J Clin Med. 2024; 13(16).

PMID: 39200742 PMC: 11354245. DOI: 10.3390/jcm13164599.

Severe Aortic Stenosis Associated with Other Valve Diseases: Open Surgery or Percutaneous Treatment?.

Moral S, Abuli M, Ballesteros E, Vilardell P, Gutierrez L, Brugada R Rev Cardiovasc Med. 2024; 25(3):99.

PMID: 39076950 PMC: 11263836. DOI: 10.31083/j.rcm2503099.

References

Topilsky Y, Maltais S, Inojosa J, Oguz D, Michelena H, Maalouf J . Burden of Tricuspid Regurgitation in Patients Diagnosed in the Community Setting. JACC Cardiovasc Imaging. 2018; 12(3):433-442. DOI: 10.1016/j.jcmg.2018.06.014. View

Sun Z, Li H, Zhang Z, Li Y, Zhang L, Xie Y . Twelve-month outcomes of the LuX-Valve for transcatheter treatment of severe tricuspid regurgitation. EuroIntervention. 2021; 17(10):818-826. PMC: 9725022. DOI: 10.4244/EIJ-D-21-00095. View

Pasta S, Cannata S, Gentile G, Di Giuseppe M, Cosentino F, Pasta F . Simulation study of transcatheter heart valve implantation in patients with stenotic bicuspid aortic valve. Med Biol Eng Comput. 2020; 58(4):815-829. DOI: 10.1007/s11517-020-02138-4. View

Barreiro-Perez M, Estevez-Loureiro R, Baz J, Pinon M, Maisano F, Puga L . Cardiovalve Transfemoral Tricuspid Valve Replacement Assisted With CT-Fluoroscopy Fusion Imaging. JACC Cardiovasc Interv. 2022; 15(17):e197-e199. DOI: 10.1016/j.jcin.2022.06.023. View

Fam N, von Bardeleben R, Hensey M, Kodali S, Smith R, Hausleiter J . Transfemoral Transcatheter Tricuspid Valve Replacement With the EVOQUE System: A Multicenter, Observational, First-in-Human Experience. JACC Cardiovasc Interv. 2021; 14(5):501-511. DOI: 10.1016/j.jcin.2020.11.045. View

Dowling C, Gooley R, McCormick L, Firoozi S, Brecker S . Patient-specific Computer Simulation: An Emerging Technology for Guiding the Transcatheter Treatment of Patients with Bicuspid Aortic Valve. Interv Cardiol. 2021; 16:e26. PMC: 8419845. DOI: 10.15420/icr.2021.09. View

Aoi S, Wiley J, Ho E, Goldberg Y, Chau M, Latib A . Transcatheter tricuspid valve implantation with the Cardiovalve system. Future Cardiol. 2021; 17(6):963-969. DOI: 10.2217/fca-2020-0181. View

Asmarats L, Dagenais F, Bedard E, Pasian S, Hahn R, Navia J . Transcatheter Tricuspid Valve Replacement for Treating Severe Tricuspid Regurgitation: Initial Experience With the NaviGate Bioprosthesis. Can J Cardiol. 2018; 34(10):1370.e5-1370.e7. DOI: 10.1016/j.cjca.2018.07.481. View

Praz F, Muraru D, Kreidel F, Lurz P, Hahn R, Delgado V . Transcatheter treatment for tricuspid valve disease. EuroIntervention. 2021; 17(10):791-808. PMC: 9724890. DOI: 10.4244/EIJ-D-21-00695. View

10.

Zhang Y, Lu F, Li W, Chen S, Li M, Zhang X . A first-in-human study of transjugular transcatheter tricuspid valve replacement with the LuX-Valve Plus system. EuroIntervention. 2022; 18(13):e1088-e1089. PMC: 9909447. DOI: 10.4244/EIJ-D-22-00517. View

11.

Taramasso M, Benfari G, Van der Bijl P, Alessandrini H, Attinger-Toller A, Biasco L . Transcatheter Versus Medical Treatment of Patients With Symptomatic Severe Tricuspid Regurgitation. J Am Coll Cardiol. 2019; 74(24):2998-3008. DOI: 10.1016/j.jacc.2019.09.028. View

12.

McCarthy P, Kislitsina O, Chris Malaisrie S, Davidson C . Transcatheter Mitral Valve Replacement with Intrepid. Interv Cardiol Clin. 2019; 8(3):287-294. DOI: 10.1016/j.iccl.2019.02.002. View

13.

Hahn R, Kodali S, Fam N, Bapat V, Bartus K, Rodes-Cabau J . Early Multinational Experience of Transcatheter Tricuspid Valve Replacement for Treating Severe Tricuspid Regurgitation. JACC Cardiovasc Interv. 2020; 13(21):2482-2493. DOI: 10.1016/j.jcin.2020.07.008. View

14.

Ning X, An Z, Qiao F, Cai C, Han L, Song Z . [Safety and efficacy of transcatheter tricuspid valve replacement with LuX-Valve in patients with severe tricuspid regurgitation]. Zhonghua Xin Xue Guan Bing Za Zhi. 2021; 49(5):455-460. DOI: 10.3760/cma.j.cn112148-20210125-00091. View

15.

Navia J, Kapadia S, Elgharably H, Harb S, Krishnaswamy A, Unai S . First-in-Human Implantations of the NaviGate Bioprosthesis in a Severely Dilated Tricuspid Annulus and in a Failed Tricuspid Annuloplasty Ring. Circ Cardiovasc Interv. 2017; 10(12). DOI: 10.1161/CIRCINTERVENTIONS.117.005840. View

16.

Wang N, Fulcher J, Abeysuriya N, McGrady M, Wilcox I, Celermajer D . Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a systematic review and meta-analysis. Eur Heart J. 2018; 40(5):476-484. DOI: 10.1093/eurheartj/ehy641. View

17.

Kodali S, Hahn R, George I, Davidson C, Narang A, Zahr F . Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation: TRISCEND Study 30-Day Results. JACC Cardiovasc Interv. 2022; 15(5):471-480. DOI: 10.1016/j.jcin.2022.01.016. View

18.

Webb J, Chuang A, Meier D, von Bardeleben R, Kodali S, Smith R . Transcatheter Tricuspid Valve Replacement With the EVOQUE System: 1-Year Outcomes of a Multicenter, First-in-Human Experience. JACC Cardiovasc Interv. 2022; 15(5):481-491. DOI: 10.1016/j.jcin.2022.01.280. View

19.

Praz F, Khalique O, Dos Reis Macedo L, Pulerwitz T, Jantz J, Wu I . Comparison between Three-Dimensional Echocardiography and Computed Tomography for Comprehensive Tricuspid Annulus and Valve Assessment in Severe Tricuspid Regurgitation: Implications for Tricuspid Regurgitation Grading and Transcatheter Therapies. J Am Soc Echocardiogr. 2018; 31(11):1190-1202.e3. DOI: 10.1016/j.echo.2018.07.007. View

20.

Lu F, Ma Y, An Z, Cai C, Li B, Song Z . First-in-Man Experience of Transcatheter Tricuspid Valve Replacement With LuX-Valve in High-Risk Tricuspid Regurgitation Patients. JACC Cardiovasc Interv. 2020; 13(13):1614-1616. DOI: 10.1016/j.jcin.2020.03.026. View